6-shogaol treatment in breast cancer cells results in the suppression of proliferation by the significant induction of apoptosis and the inhibition of autophagy by the regulation of the Notch signaling pathway (Hes1 and CyclinD1 genes). This evidence concerns the gene HES1 and breast cancer.